SCHEMBL753052

SCHEMBL753052

Fc1ccc(Cn2cc(Br)cn2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 3/20 0.64
▸ MAPK1 P28482 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ TSHR P16473 1/20 0.64
▸ LMNA P02545 6/20 0.63
▸ MAPT P10636 3/20 0.63
▸ ALDH1A1 P00352 7/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ HTT P42858 3/20 0.53
▸ GAA P10253 2/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ CREBBP Q92793 1/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ USP2 O75604 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ TCF4 P15884 1/20 0.41
▸ CTNNB1 P35222 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16875924 0.84 HSD17B10 (0.66) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL671242 0.81 TSHR (0.63) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL24628398 0.81 KMT2A (0.59) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL21054803 0.81 HSD17B10 (0.55) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL16095293 0.79 LMNA (0.63) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL3611556 0.79 MAPT (0.97) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL3084412 0.79 LMNA (0.63) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL2902778 0.79 HSD17B10 (0.59) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL25561729 0.78 KMT2A (0.59) HSD17B10MAPK1KMT2ATSHRLMNA
SCHEMBL18097766 0.78 TSHR (0.55) HSD17B10MAPK1KMT2ATSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266958-B1 Antiviral agent SHIONOGI & CO (JP) 2017-03-15 — — EP disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 — — US disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 — — US disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 — — US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 — — US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 — — US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 — — US disclosed
EP-3042894-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2016-07-13 — — EP disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 — — US disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 — — US disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 — — US disclosed
EP-1422218-B1 ANTIVIRAL AGENT SHIONOGI & CO (JP) 2012-03-21 — — EP disclosed
CN-101513402-B Antiviral agent SHIONOGI & CO 2012-03-21 — — CN disclosed
EP-2266958-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2010-12-29 — — EP disclosed
EP-2181985-A1 Antiviral Agent SHIONOGI & CO., LTD. (JP) 2010-05-05 — — EP disclosed
CN-101513402-A Antiviral agent SHIONOGI & CO (JP) 2009-08-26 — — CN disclosed
CN-100491349-C Antiviral agent SHIONOGI & CO (JP) 2009-05-27 — — CN disclosed
CN-1558898-A Antiviral agent ��Ұ����ҩ��ʽ���� 2004-12-29 — — CN disclosed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150202208-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI HSD17B10 1765/4885MAPK1 3073/4885KMT2A 667/4885
US-20170066754-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI HSD17B10 1765/4885MAPK1 3073/4885KMT2A 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback